GSK Will Cut Sales Force And Reinvest In R&D If Pfizer Acts First

Company would “welcome” a decision by Pfizer to cut back its sales force, CEO Garnier declares. Analyst reports have ignited market speculation that Pfizer is ready to retool its sales and marketing infrastructure.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet